Benzodiazepine Tapering Guidelines Pocket Guide - Guideline Central

Benzodiazepine Tapering

American Society of Addiction MedicinePublished: March 4, 2025

A PDF version of this Pocket Guide is also available!
$11.95
  • Key Points
    • Background
    • Key Takeaways
  • Guiding Principles
  • Recommendations
  • Figures and Algorithms
    • Determine Whether and Where to Taper
    • Taper Management — Outpatient
  • Tables
    • Potential Benefits and Risks of Continued BZD Use and BZD Tapering
    • Risk for Clinically Significant BZD Withdrawal
    • Common Benzodiazepine Withdrawal Signs and Symptoms
    • Benzodiazepine Tapering Considerations by Pregnancy Trimester
    • Relative Infant Dose (RID) of BZD Medications
    • Sample Residential (Level 3.7) Protocol for Phenobarbital Taper
    • Benzodiazepine Approximate Dose Equivalents to 10 mg Oral Diazepam
    • Pharmacokinetic Properties of Benzodiazepines
    • Adjunctive Psychosocial Interventions
    • Medications for Anxiety-Related Symptoms
    • Medications for Insomnia-Related Symptoms


You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.